All coronavirus articles – Page 10
-
OpinionChemists amid coronavirus: Núria López
The Spanish scientific superstar is at home, but busier than ever trying to get researchers access to Europe’s supercomputers to fight Covid-19
-
NewsUK seeks to scale-up Covid-19 testing but large gaps in capabilities remain
Universities and research labs are being brought in to help with testing but 100,000 tests per day by the end of April still looks overly ambitious
-
OpinionChemists amid coronavirus: Laurean Ilies
As Japan declares an emergency state, a Romanian team leader at Riken uneasily shuts down his lab
-
OpinionChemists amid coronavirus
How chemists around the world are coping with life and work during the Covid-19 pandemic
-
NewsEuropean Research Council president quits after three months in the job
Mauro Ferrari walks away following ‘unanimous rejection’ of coronavirus response plan
-
OpinionChemists amid coronavirus: Helen Sharman
A former space-travelling chemist finds she has to rejig her work here on Earth as a science communicator
-
NewsOpen source antiviral dataset released to aid fight against Covid-19
CAS collection hosts 50,000 compounds with potential to treat coronavirus infections
-
NewsUK’s largest funder aims to raise $8 billion in three weeks for coronavirus research
The Wellcome Trust’s Covid-Zero initiative calls on businesses to bridge the funding shortfall
-
NewsPublisher expresses reservations about hydroxychloroquine study it printed
Study claimed malaria drug could treat Covid-19
-
NewsPandemic pushes world’s largest cancer charity to cut research funding by £44 million
Cancer Research UK slashes grant money and national centres funds
-
OpinionChemists amid coronavirus: Edgar Cahoon
Labs are still open at the University of Nebraska in Lincoln, US, but it’s not business as usual
-
OpinionChemists amid coronavirus: Dick Zare
As part of a new series looking at how chemists are affected by Covid-19, Dick Zare relates how manuscripts and Zoom calls have kept him busy in self-isolation.
-
PodcastRemdesivir
Will new clinical trials for Covid-19 give remdesivir a second chance? Ben Valsler introduces the broad-spectrum antiviral that didn’t quite make it as the Ebola drug it was originally planned to be
-
BusinessMystery surrounds UK claim of Covid-19 test reagent ‘shortage’
Suppliers are stepping up production to meet demand as UK targets mass testing
-
ResearchStructural studies offer glimpse of how coronavirus initiates human cell invasion
Researchers studying virus receptor-binding domains suggest virus could have passed directly from bats to humans
-
OpinionVaccine development against the clock
How long will it take to develop a coronavirus vaccine and why is it so hard?
-
BusinessCan existing drugs slow Covid-19?
The fastest route to treatments may be to repurpose existing drugs – if they work
-
PodcastChloroquine and hydroxychloroquine
The Covid-19 pandemic – and some very high profile backing – has led to malaria drugs chloroquine and hydroxychloroquine hitting the headlines worldwide.
-
ResearchPotent coronavirus drug candidate designed using 3D structure of key viral enzyme
Inhibitor of Sars-CoV-2 protease shows promise in early animal tests
-
NewsUK researchers receive £20m to start coronavirus treatment research
Two vaccine trials among six projects that win funding